Accelerated DMN-Targeted cTBS Improves Processing Speed Deficits in Schizophrenia

Processing speed improves with DMN-targeted cTBS, indicating potential benefits in cognitive functions.
The primary metric observed is a notable reduction in cognitive impairment associated with schizophrenia.
Personalized network targeted TMS was employed to assess cognitive function enhancement across affected individuals.
Further research is needed to explore broader implications of TMS intervention on cognitive abilities.

In sum, personalized network targeted TMS is a novel method for reducing cognitive impairment associated with schizophrenia.

Cite This Study